HR 5882 · 116th Congress · Health

GENE Therapy Payment Act

Introduced 2020-02-12· Sponsored by Rep. Schrader, Kurt [D-OR-5]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Energy and Commerce.(2020-02-12)

Plain Language Summary

[AI summary unavailable — showing source text] Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (6)

2 Democrats4 Republicans